Panion & Bf Biotech (TPE:1760) General and Admin. Expense: NT$176 Mil (TTM As of Dec. 2025)


TPE:1760 Panion & Bf Biotech Inc TPE:1760
73 GF Score
Price NT$65.90
GF Value NT$96.01
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Panion & Bf Biotech General and Admin. Expense?

Panion & Bf Biotech TPE:1760 +4.60% 73 General and Admin. Expense is NT$176 Mil as of Dec. 2025. GuruFocus rates TPE:1760 with a GF Score™ of 73/100 and a GF Value™ of NT$96.01 (Significantly Undervalued). The stock has 4 warning signs investors should review.

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. Panion & Bf Biotech's General and Admin. Expense for the three months ended in Dec. 2025 was NT$51 Mil. Its General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 was NT$176 Mil.

Panion & Bf Biotech General and Admin. Expense Related Terms

Panion & Bf Biotech General and Admin. Expense Historical Data

* Premium members only.

The historical data trend for Panion & Bf Biotech's General and Admin. Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Panion & Bf Biotech General and Admin. Expense Chart

Panion & Bf Biotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
General and Admin. Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 190.32 233.91 175.94 162.01 175.65

Panion & Bf Biotech Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
General and Admin. Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 39.78 37.36 41.26 45.99 51.05
TPE:1760
73GF Score
Panion & Bf Biotech Inc TPE:1760
General and Admin. Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Panion & Bf Biotech General and Admin. Expense Calculation

General and Admin. Expense is the aggregate total of general managing and administering expenses for the company.

General and Admin. Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$176 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a General and Admin. Expense of NT$176 Mil mean?
Panion & Bf Biotech (TPE:1760) has a General and Admin. Expense of NT$176 Mil as of Dec. 2025. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Panion & Bf Biotech and its competitors.
Is Panion & Bf Biotech's General and Admin. Expense too high?
Panion & Bf Biotech's current General and Admin. Expense is NT$176 Mil. Overall, Panion & Bf Biotech has a GF Score™ of 73/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Panion & Bf Biotech's General and Admin. Expense compare to VRTX and REGN?
Panion & Bf Biotech's General and Admin. Expense of NT$176 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good General and Admin. Expense for a Drug Manufacturers company?
A good General and Admin. Expense depends on the Drug Manufacturers industry context. However, General and Admin. Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high General and Admin. Expense mean?
A high General and Admin. Expense can signal that a stock is expensive relative to its fundamentals. General and Admin. Expense is the aggregate total of general managing and administering expenses for the company. View historical data on Panion & Bf Biotech and its competitors. Panion & Bf Biotech's current General and Admin. Expense is NT$176 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panion & Bf Biotech stock overvalued right now?
Based on GuruFocus' analysis, Panion & Bf Biotech (TPE:1760) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$96.01, compared to a current price of NT$65.90 — trading 31.4% below its estimated fair value. The current General and Admin. Expense is NT$176 Mil. Panion & Bf Biotech's overall GF Score™ is 73/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is General and Admin. Expense calculated?
General and Admin. Expense is calculated from a company's financial statements. For Panion & Bf Biotech (TPE:1760), the current General and Admin. Expense is NT$176 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Panion & Bf Biotech (TPE:1760) Overvalued in 2026?

Based on GuruFocus' analysis, Panion & Bf Biotech stock appears to be undervalued. The current stock price of NT$65.90 is trading 31.4% below its estimated GF Value™ of NT$96.01. GuruFocus considers Panion & Bf Biotech to be Significantly Undervalued.

Key valuation signals for TPE:1760:

  • General and Admin. Expense: NT$176 Mil
  • GF Value™: NT$96.01 vs. price of NT$65.90 (31.4% below fair value)
  • GF Score™: 73/100 with 4 warning signs

No single metric tells the full story. See the TPE:1760 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Panion & Bf Biotech Business Description

Address No. 3, Park Street, 16th Floor, Nangang District, Taipei, TWN, 11503
Panion & Bf Biotech Inc operates as a biotech and pharmaceutical company. The company, along with its subsidiaries, is mainly engaged in the manufacture and sales of pharmaceutical, cosmeceutical, diagnostic, medical device, and active pharmaceutical ingredients. It has four core business groups: disease treatment, disease prevention, disease diagnosis, and delayed aging. It has geographic segments in Taiwan; China, Hong Kong, and Macau; the USA; and Korea. It generates a majority of its revenue from the Taiwan segment. Product-wise the firm generates the majority of its revenue from Pharmaceutical products.
73GF Score

Get the complete analysis for TPE:1760

General and Admin. Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$65.90
Price
NT$96.01
GF Value